I'm Miguel, an engineer at Gencove.
We've just launched a new consumer product that provides genetic insights using low-pass sequencing rather than traditional microarrays.
For now we offer 9 polygenic risk scores based on the eMERGE network paper: https://www.nature.com/articles/s41591-024-02796-z
After receiving results, you can download your VCF directly (no need to go through support).
Happy to answer questions about the tech, accuracy tradeoffs, or how this compares to array-based approaches.
This is the only low-pass sequencing based consumer product that provides health results